LTRN Lantern Pharma Inc
Company Analysis
Latest News
🔴 Lantern Pharma is trading 6.3% down with no clear company-specific catalyst identified
Lantern Pharma is trading 6.3% lower at $0.63 on October 16, 2026, with no clear company-specific catalyst identified. - Major U.S. indexes are lower, and...
🟢 Lantern Pharma is trading 10% up; catalyst remains unclear
Lantern Pharma is trading at $0.73, up +10.21%, with the catalyst unclear as of 9:50 a.m. ET on October 16, 2026. - No clear company-specific announcement...
🔴 Lantern Pharma is trading 5.6% down as hotter-than-expected inflation weighs on growth stocks
Lantern Pharma is trading 5.6% down at $0.67, with broad market pressure after hotter-than-expected inflation data the likeliest explanation. - Major indexes...
🔴 Lantern Pharma is trading 5% down today with no clear company-specific catalyst identified
Lantern Pharma is trading 5.02% down at $0.70 on October 13, 2026, with no clear company-specific announcement identified to explain the decline. - Its latest...
🔴 Lantern Pharma is trading 10.2% down amid an unexplained stock-specific move
Lantern Pharma is trading 10.16% down at $0.73 on October 12, 2026, in an unexplained stock-specific move. - No clear company-specific announcement explaining...
🔴 Lantern Pharma is trading 6.5% down with no identified catalyst
Lantern Pharma is trading 6.48% down at $0.76 on October 12, 2026, with no clear company-specific catalyst identified. - The latest company announcements were...
🔴 Lantern Pharma is trading 5% down in pre-market
Lantern Pharma is trading at $0.77, with a -5.22% change in the October 12 pre-market; no clear company-specific catalyst was identified. - The company’s...
🔴 Lantern Pharma is trading 6% down
Lantern Pharma is trading at $0.78, down 6.01% at 10:45 a.m. ET on October 9; no clear company-specific catalyst for the decline has been identified. - The...
🔴 Lantern Pharma is trading 7.4% down with no clear company-specific catalyst
Lantern Pharma is trading 7.4% lower at $0.84, with no company-specific news explaining the decline. - Lantern Pharma announced a ThinkEquity Conference...
🟢 Lantern Pharma is trading 5% up in pre-market after Taiwan approvals advanced HARMONIC Part 2
Lantern Pharma is trading 5.49% up at $0.96 in pre-market, with trial advancement a plausible catalyst. - On October 7, Taiwan regulators and an institutional...
🔴 Lantern Pharma is trading 5.61% down on October 7, 2026 as biotech stocks faced pressure
Lantern Pharma is trading at $0.90, down 5.61%, amid biotech-sector weakness. - No October 7, 2026 company-specific announcement was identified; the latest...
🟢 Lantern Pharma is trading 11% up with no confirmed catalyst
Lantern Pharma is trading 10.63% higher at $1.04 on October 6, 2026; no confirmed company-specific catalyst was found. - The latest release listed on the...
🟢 Lantern Pharma is trading 11% up today with no confirmed catalyst identified
Lantern Pharma is trading 10.96% higher at $0.95 on October 5, 2026, following a sharp recent decline; no confirmed company-specific catalyst for the rebound...
🟢 Lantern Pharma is trading 7.2% up today with no confirmed catalyst identified
Lantern Pharma is trading 7.21% up at $0.92 on October 5 after a steep recent decline; no confirmed catalyst for the rebound was found. - A September 30...
🔴 Lantern Pharma is trading 10.3% down today amid recent registered direct offering; link remains unconfirmed
Lantern Pharma is trading 10.3% lower at $0.90; the offering is relevant context, not a confirmed cause. - Closed September 30, 2026, the offering raised...
🔴 Lantern Pharma is trading 5.9% down today amid recent registered direct offering
Lantern Pharma is trading 5.9% down at $0.94 amid a recent offering; reporting has not confirmed it caused the October 2 move. - The company closed a...
Lantern Pharma Raises $4 Million Selling Stock Near Its Lows — Is This Survival Financing or a Springboard?
Shares of Lantern Pharma jumped 10% to $1.10 in pre-market trading on October 2, the day after the clinical-stage cancer biotech confirmed it closed a...
🟢 Lantern Pharma is trading 10% up in pre-market after raising $4 million in registered direct offering
Lantern Pharma is trading 10% up at $1.10 in pre-market on October 2, 2026, following the close of its registered direct offering. - Announced October 1, the...
Lantern Pharma Receives Nasdaq Non-Compliance Notice for Market Value Requirement
Lantern Pharma Inc. (LTRN) received a notice from The Nasdaq Stock Market on September 25, 2026, indicating that the company is not in compliance with the...
Lantern Pharma Closes $4.0 Million Registered Direct Offering and Private Placement
Lantern Pharma Inc. has closed a registered direct offering and a concurrent private placement with an institutional investor, raising gross proceeds of...